Allogeneic adipose-derived stromal cells (JKastrup)

N/A

Report date: 2024/11/13 20:00:43

Base Information

Drug NameAllogeneic adipose-derived stromal cells (JKastrup)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Stromal cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsCardiomyopathy, Dilated

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLjubljana University Medical Centre

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLjubljana University Medical Centre

Active IndicationsN/A

Inactive IndicationsCardiomyopathy, Dilated

Other Information

ATC CodeN/A